An Overview on Hyperthyroidism, Evaluation and Management Approach in Primary Health Care Centre
Authors:
- 1 January 2021
- journal article
- review article
- Published by Polaris in Archives Of Pharmacy Practice
- Vol. 12 (2) , 134-139
Abstract
Hyperthyroidism is specified by the mass manufacture of thyroid hormone and/or release from the thyroid gland. Thyrotoxicosis is a sickness in which the impacts of an inappropriate enhancement in thyroid hormone on tissues lead to difficulties and systemic symptoms. High thyroid hormone levels cause a hyper metabolic condition that induces multiple systemic manifestations. Managing hyperthyroidism cases is considered a difficult challenge because of the variety of the underlying causes and the vKeywords
This publication has 28 references indexed in Scilit:
- The epidemiology of thyroid diseaseBritish Medical Bulletin, 2011
- Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical EndocrinologistsThyroid®, 2011
- Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidismMolecular and Cellular Endocrinology, 2010
- Management of thyroid disorders in primary care: challenges and controversiesPostgraduate Medical Journal, 2009
- Thyroid Disease and the HeartCirculation, 2007
- Diagnosis and management of thyrotoxicosisBMJ, 2006
- The Cost Effectiveness of Treatment Modalities for Thyrotoxicosis in a U.K. CenterThyroid®, 2006
- ThyroiditisNew England Journal of Medicine, 2003
- Sibling Recurrence Risk in Autoimmune Thyroid DiseaseThyroid®, 2003
- Graves' DiseaseNew England Journal of Medicine, 2000